Jennifer Robinson

Contacto de Relaciones con Inversores en VERVE THERAPEUTICS, INC. .

Health Technology

Consumer Services

Cargos activos de Jennifer Robinson

Empresas	Cargo	Inicio	Fin
VERVE THERAPEUTICS, INC.	Contacto de Relaciones con Inversores	-	-
VERVE THERAPEUTICS, INC.	Public Communications Contact	-	-

Empresas	Cargo	Inicio	Fin
DYAX CORP.	Contacto de Relaciones con Inversores	01/10/2011	01/04/2016
DYAX CORP.	Public Communications Contact	01/10/2011	01/04/2016
RA PHARMACEUTICALS, INC.	Contacto de Relaciones con Inversores	-	-
RA PHARMACEUTICALS, INC.	Public Communications Contact	-	-
DECIPHERA PHARMACEUTICALS, INC.	Contacto de Relaciones con Inversores	-	-
DECIPHERA PHARMACEUTICALS, INC.	Public Communications Contact	-	-
ADICET BIO, INC.	Contacto de Relaciones con Inversores	01/06/2018	-
ADICET BIO, INC.	Public Communications Contact	01/06/2018	-

Dartmouth College

Undergraduate Degree

Internacional

Estados Unidos

Operativa

Investor Relations Contact	5
Public Communications Contact	5
Undergraduate Degree	1

Sectorial

Health Technology	6
Consumer Services	2

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	2
DECIPHERA PHARMACEUTICALS, INC.	Health Technology
VERVE THERAPEUTICS, INC.	Health Technology

Empresas privadas	3
Dyax Corp. Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA.	Health Technology
resTORbio, Inc. resTORbio, Inc. BiotechnologyHealth Technology resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.	Health Technology
Ra Pharmaceuticals, Inc. Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.	Health Technology